Global Botulinum Toxins Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research. Scope of the Report: In the last several years, global market of Botulinum Toxins developed rapidly, with an average growth rate of 14.6%. In 2017, global revenue of Botulinum Toxins is nearly 4000 million USD; the actual production is about 12.4 million units. The classification of Botulinum Toxins includes 50U, 100U and other, and the sales proportion of 50U in 2017 is about 59.3%. Botulinum Toxins is used for medical and cosmetic. Medical was the largest application segment in 2017, the proportion is about 51%. The worldwide market for Botulinum Toxins is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 8500 million US$ in 2024, from 4550 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Botulinum Toxins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Allergan Ipsen Merz Pharmaceuticals Medytox US World Meds LIBP Market Segment by Regions, regional analysis covers North Ame ...
Table of Contents 1 Market Overview 1.1 Botulinum Toxins Introduction 1.2 Market Analysis by Type 1.2.1 50U 1.2.2 100U 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 Medical 1.3.2 Cosmetic 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast ...
4739

1834

OUR CLIENT